Provided by Tiger Trade Technology Pte. Ltd.

Soleno Therapeutics

41.53
+1.954.93%
Post-market: 41.05-0.4800-1.16%19:57 EST
Volume:1.46M
Turnover:59.51M
Market Cap:2.23B
PE:-23.73
High:41.80
Open:40.32
Low:39.55
Close:39.58
52wk High:90.32
52wk Low:37.95
Shares:53.71M
Float Shares:44.87M
Volume Ratio:0.65
T/O Rate:3.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7500
EPS(LYR):-4.3770
ROE:-20.66%
ROA:-11.75%
PB:4.51
PE(LYR):-9.49

Loading ...

Soleno Therapeutics options imply 15.9% move in share price post-earnings

TIPRANKS
·
Nov 05, 2025

Did New Legal Scrutiny Around VYKAT XR Just Shift Soleno Therapeutics' (SLNO) Investment Narrative?

Simply Wall St.
·
Nov 02, 2025

Soleno Therapeutics to Participate in Upcoming November Conferences

GlobeNewswire
·
Oct 28, 2025

Cassava Sciences Appoints Dawn C. Bir to Board of Directors

Reuters
·
Oct 22, 2025

Soleno Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025, at 4:30 PM ET

GlobeNewswire
·
Oct 21, 2025

Does Soleno Therapeutics’ (SLNO) Board Expansion Hint at a Shift in Governance Amid VYKAT XR Scrutiny?

Simply Wall St.
·
Oct 18, 2025

Soleno Therapeutics Files Initial Statement of Beneficial Ownership for Director Mark W. Hahn

Reuters
·
Oct 15, 2025

Press Release: Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors

Dow Jones
·
Oct 13, 2025

Soleno Therapeutics (SLNO): Valuation in Focus After Scorpion Capital Report and Legal Probes on VYKAT XR

Simply Wall St.
·
Oct 12, 2025

Soleno Therapeutics initiated with a Buy at Goldman Sachs

TIPRANKS
·
Oct 07, 2025

Buy Rating for Soleno Therapeutics: Strong Market Potential and Growth Opportunities with Vykat XR

TIPRANKS
·
Oct 07, 2025

TD Cowen Keeps Their Buy Rating on Soleno Therapeutics (SLNO)

TIPRANKS
·
Oct 06, 2025

Soleno Therapeutics Inc : Stifel Cuts Target Price to $115 From $118

THOMSON REUTERS
·
Oct 01, 2025

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Soleno Therapeutics (SLNO)

TIPRANKS
·
Sep 29, 2025

Robert W. Baird Sticks to Their Buy Rating for Soleno Therapeutics (SLNO)

TIPRANKS
·
Sep 25, 2025

Video: Soleno Therapeutics stock rallies on competitor’s failed trial

TIPRANKS
·
Sep 25, 2025

Wells Fargo Sticks to Their Buy Rating for Soleno Therapeutics (SLNO)

TIPRANKS
·
Sep 25, 2025

Stifel Nicolaus Remains a Buy on Soleno Therapeutics (SLNO)

TIPRANKS
·
Sep 25, 2025

BUZZ-Soleno Therapeutics rises after rival's rare disease drug fails late-stage study

Reuters
·
Sep 24, 2025

Soleno Therapeutics rises 10.6%

TIPRANKS
·
Sep 24, 2025